Evaluation of the pro-oxidant and antioxidant actions of L-DOPA and dopamine in vitro: Implications for Parkinson's disease

Free Radical Research

Volumn 24, Issue 2, 1996, Pages 95-105

  Spencer, Jeremy P E ^a   Jenner, Andrew ^a   Butler, John ^b   Aruoma, Okezie I ^a   Dexter, David T ^a   Jenner, Peter ^a   Halliwell, Barry ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Antioxidants; Dopamine; Free radicals; L DOPA; Peroxyl radicals

Indexed keywords

ALPHA 1 ANTITRYPSIN; ANTIOXIDANT; CHELATE; DOPAMINE; EDETIC ACID; FERRIC CITRATE; HYDROGEN PEROXIDE; HYDROXYL RADICAL; HYPOCHLOROUS ACID; LEVODOPA; OXIDIZING AGENT; PHOSPHOLIPID; SUPEROXIDE;

ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; ENZYME INHIBITION; LIPID PEROXIDATION; NEUROLOGIC DISEASE; OXIDATIVE STRESS; PARKINSON DISEASE;

EID: 0030028316     PISSN: 10715762     EISSN: None     Source Type: Journal    
DOI: 10.3109/10715769609088005     Document Type: Article

References (51)

1. G. Cohen (1986) Monoamine oxidase, hydrogen peroxide and Parkinson's disease. Advances in Neurology, 45, 119-125.
2. T. Yoshikawa (1993) Free radicals and their scavengers in Parkinson's disease. European Journal of Neurology, 33, (suppl 2) 60-68.
3. P. Riederer, E. Sofic, W.D. Rausche, B. Schmidt, G.P. Reynolds, K. Jallinger and M.B.H. Youdim (1989) Transition metals, ferritin, glutathione and ascorbic acid in Parkinsonian brains. Journal of Neurochemistry, 52, 515-520.
4. P. Jenner (1989) Oxidative stress as a cause of Parkinson's disease. Acta Neurologica Scandinavica, 84, (suppl. 136), 6-15.
5. J.T. Coyle and P Puttfarcken (1993) Oxidative stress, glutamate and neurodegenerative disorders. Science, 262, 689-695.
6. M.B. Spina and G. Cohen (1989) Dopamine turnover and glutathione oxidation: implications for Parkinson disease. Proceedings of the National Academy of Science, USA, 86, 1398-1400.
7. C.W. Olanow (1993) A radical hypothesis for neurodegeneration. Trends in Neuroscience, 16, 439-444.
8. J.L Cadet (1988) A unifying hypothesis of movement and madness: involvement of free radical in disorders of the isodendritic core. Medical Hypotheses, 27, 87-94.
9. B. Halliwell and J.M.C. Gutteridge (1985) Oxygen radicals and the nervous system. Trends in Neuroscience, 8, 22-26.
10. B. Halliwell (1992) Reactive oxygen species and the central nervous system. Journal of Neurochemistry, 59, 1609-1623.
11. J.A. Dykens, A. Stern and E Trenker (1987) Mechanism of kainate toxicity to cerebellar neurons in vitro is analogous to reperfusion tissue injury. Journal of Neurochemistry, 49, 1222-1228.
12. E.D. Hall and J.M. Braughler (1988) The role of oxygen radical-induced lipid peroxidation in acute central nervous system trauma. In Oxygen Radicals and Tissue Injury (Halliwell, B. ed), pp. 92-98. FASEB: Bethesda.
13. J.M. Camey, P.E. Starke-Reed, C.N. Oliver et al. (1991) Reversal of age-related changes in brain protein oxidation, decrease in enzyme activity, and loss, in temporal and spatial memory by chronic administration of the spin trapping compound N-tert-butyl-a-phenylnitrone. Proceedings of the National Academy of Science USA, 88, 3633-3636.
14. M.B.H. Youdim (1988) Brain Iron. Neurochemical and Behavioural Aspects. Taylor and Francis, New York.
15. M.B.H. Youdim, D. Ben-Shachar and P. Riederer (1993) The possible role of iron in the etiopathology of Parkinson's disease. Movement Disorder, 8, 1-12.
16. L. Zecca, R. Pietra, C. Goj, C. Mecacci, D. Radice and E. Sabbioni (1994) The possible role of iron in the etiopathology of Parkinson's disease. Journal of Neurochemistry, 62, 1097-1101.
17. D. Ben-Shachar, P. Riederer and M.B.H. Youdim (1991) Iron-melanin interaction and lipid peroxidation: implications for Parkinson's Disease. Journal of Neurochemistry, 57, 1609-1614.
18. D.T. Dexter, F.R. Wells, A.J. Lees et al. (1989) Increased nigra iron content and alterations in other metal ions occurring in brain in Parkinson's disease. Journal of Neurochemistry, 52, 1830-1836.
19. M. Tanaka, A. Sotomatsu, H. Kanai and S. Hirai (1991) Dopa and dopamine cause cultured neuronal death in the presence of iron. Journal of Neurological Science, 101, 198-203.
20. C. Marrel, G. Boss, H. van de Waterbeemd, D. Cooper, P. Jenner and C.D. Marsden (1985) L-DOPA esters as potential pro-drugs. Part 1. Physicochemical properties. European Journal of Medicinal Chemistry, 20, 459-465.
21. D G. Graham (1978) Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Molecular Pharmacology, 14, 633-643.
22. A. Bindoli, M.P. Rigobello and D.J. Deeble (1992) Biochemical and toxicological properties of the oxidation products of catecholamines. Free Radical Biology & Medicine, 13, 391-405.
23. P. Moldéus, M. Nordenskjöld, G. Bolasfoldi, A. Eiche, U. Haglund and B. Lambert (1983) Genetic toxicity of dopamine. Mutation Research, 124, 9-24.
24. B. Fornstedt, E. Pileblad and A. Carlsson (1990) In vivo autoxidation of dopamine in guinea pig striatum increases with age. Journal of Neurochemistry, 5, 655-659.
25. J.R. Sanchez-Ramos, E Overvik and B.N. Ames (1994) A marker of oxyradical-mediated DNA damage (8-hydroxy-2′-deoxy-guanosine) is increased in nigro-striatum of Parkinson's disease brain. Neurodegeneration, 3, 197-204.
26. N. Ogawa, M. Asanuma, Y. Kondo, Y. Kawada, M. Yamamoto and A. Mori (1994) Differential effects of chronic L-DOPA treatment on lipid peroxidation in the mouse brain with or without pre-treatment with 6-hydroxydopamine. Neuroscience Letters, 171, 55-58.
27. B. Halliwell (1990) How to characterize a biological anti-oxidant. Free Radical Research Communications, 9,1-32.
28. G.J. Quinlan, B. Halliwell, C.P. Moorhouse and J.M.C. Gutteridge (1988) Action of lead (II) and aluminium (III) ions on iron-stimulated lipid peroxidation in liposomes, erythrocytes and rat liver microsomal fractions. Biochimica et Biophysica Acta, 962, 196-200.
29. R.L. Willson (1985) Organic peroxyl free radicals as ultimate agents in oxygen toxicity. In Oxidative Stress, (H. Sies ed), Academic Press: London, pp. 41-72.
30. O.I. Aruoma, B. Halliwell, R. Aeschbach and J. Loliger (1992) Antioxidant and pro-oxidant properties of active rosemary constituents: carnosol and carnosic acid. Xenobiotica, 22, 257-268.
31. J.M. McCord and I. Fndovich (1969) Superoxide dismutase. An enzyme function for erythrocuprein (hemocuprein). Journal of Biological Chemistry, 244, 6049-6055.
32. B. Halliwell, J.M.C. Gutteridge and O.I. Aruoma (1987) The deoxyribose method: a simple test-tube assay for determination of rate constants for reactions of hydroxyl radical. Analytical Biochemistry, 165, 215-219.
33. 1-antiproteinase by hypochlorous acid and by hydrogen peroxide. Biochemical Journal, 243, 219-223.
34. O.I. Aruoma and B. Halliwell (1987) Action of hypochlorous acid on the antioxidant protective enzymes superoxide dismutase, catalase and glutathione peroxidase. Biochemical Journal, 248, 973-976.
35. B.C. Scott, O.I. Aruoma, P.J. Evans, C. O'Neill, A. van der Vliet, C.E. Cross, H. Tritschler and B. Halliwell (1993) Lipoic and dihydrolipoic acids as antioxidants. A critical evaluation. Free Radical Research, 20, 119-133.
36. O.I. Aruoma (1994) Nutrition and health aspects of free radicals and antioxidants. Food and Chemical Toxicology, 37, 671-685.
37. B. Halliwell (1985) Use of desferrioxamine as a probe for iron-dependent formation of hydroxyl radicals. Evidence for a direct reaction between desferal and the superoxide radical. Biochemical Pharmacology, 34, 229-233.
38. - radicals in aqueous solution. Journal of Physical and Chemical Reference Data, 14, 1041-1100.
39. S.J. Weiss (1989) Tissue destruction by neutrophils. New England Journal of Medicine, 320, 365-376.
40. J.H.T.M. Ploemen, B. Van Ommen, A. De Haan, J.C. Venekamp and P.J. Van Bladerers (1994) Inhibition of human glutathione-S-transferases by dopamine, α-methyldopa and their 5-S-glutathionyl conjugates. Chemico-Biological Interactions, 90, 87-99.
41. B. Halliwell and J.M.C. Gutteridge (1984) Oxygen toxicity, oxygen radicals, transition metals and disease. Biochemical Journal, 219, 10-14.
42. M. Grootveld, J.D. Bell, B. Halliwell, O.I. Aruoma, A. Bornford and P.J. Sadler (1989) Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy. Journal of Biological Chemistry, 264, 4417-4422.
43. H.W. Richter and W.H. Waddell (1983) Mechanism of the oxidation of dopamine by the hydroxylradical in aqueous solution. Journal of the American Chemical Society, 105, 5434-5440.
44. -. Free Radical Biology & Medicine, 13, 581-583.
45. M.B. Spina and G. Cohen (1988) Exposure of school synaptosomes to L-Dopa increases levels of oxidized glutathione. Journal of Pharmacology and Experimental Therapeutics, 247, 502-507.
46. N.E. Anden, K. Fuxe, B. Hamberger and T. Hokfelt (1966) A quantitative study on the nigro-straital dopamine neuron system in the rat. Acta Physiologica Scandinavica, 67, 306-312.
47. E.R. Stadtman and D.N. Oliver (1991) Metal-catalyzed oxidation of proteins. Physiological consequences. Journal of Biological Chemistry, 266, 2005-2008.
48. B. Halliwell and O.I. Aruoma (1991) DNA damage by oxygen-derived species: its mechanism and measurement in mammalian systems. FEBS Letters, 281, 9-19.
49. J.P.E. Spencer, A. Jenner, O.I. Aruoma, P.J. Evans, H. Kaur, D.T. Dexter, P. Jenner, A.J. Lees, D.C. Marsden and B. Halliwell (1994) Intense oxidative DNA damage promoted by L-DOPA and its metabolites. Implications for neurodegenerative disease. FEBS Letters, 353, 246-250.
50. B. Halliwell, J.M.C. Gutteridge and C.E. Cross (1992) Free radicals, antioxidants, and human disease: where are we now? Journal of Laboratory and Clinical Medicine, 119, 598-620.
51. J.P.E. Spencer, P. Jenner and B. Halliwell (1995) Superoxide-dependent GSH depletion by L-DOPA and dopamine. Relevance to Parkinson's disease. Neuro Report, 6, 1480-1484.